IAK-N -1.6308 AQN-T -0.03 AMGN-Q -5.3 META-Q -28.21 EXPE-Q -6.48 DASH-N -9.42 PLUG-Q -0.36
Sernova Biotherapeutics Inc (SVA-T)

Sernova Biotherapeutics Inc (SVA-T)

0.00
-0.00 (0.00%)
59 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0

Related posts

Nervous markets await Nvidia
BUY

Sernova Biotherapeutics Inc (SVA-T)

May 13, 2021
Credit card sized pouch inserted under the skin into which insulin cells are inserted. Control highs and lows of insulin. Also works with thyroid cells. Distribution platform for many drugs. Very positive. Revolutionary. His 12-month price target is $2.50-3, subject to outcome of trials.
PresidentRobert McWhirter
Owned
Unlock Rating
$1.330

Stock price when the opinion was issued

biotechnology
BUY

Sernova Biotherapeutics Inc (SVA-T)

Apr 12, 2021
They produce a credit card-size device beneath the skin to produce to produce insulin and regulate body sugar levels. This helps diabetics and those with thyroid conditions. Testing results have been positive. He's optimistic about this.
PresidentRobert McWhirter
Owned
Unlock Rating
$1.570

Stock price when the opinion was issued

biotechnology
BUY

Sernova Biotherapeutics Inc (SVA-T)

Feb 17, 2021

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The stock probably has some legs. The Type 1 diabetes treatment they are working on is getting lots of attention. Trials continue to show results and they have raised money and signed agreements with large companies. It is a new biotech play and the potential market is very large. Unlock Premium - Try 5i Free

Billy 5i Research Coverag…Stockchase Insights
Unknown
Unlock Rating
$1.650

Stock price when the opinion was issued

biotechnology
BUY

Sernova Biotherapeutics Inc (SVA-T)

Jan 05, 2021
Disclosure: He's helped with 2-3 of their financings recently. They make a credit-card sized pouch inserted under the skin that produces insulin to reduce extreme high or low insulin levels. That pouch can be used for many other applications in the future. Results are coming soon. SVA has broken out from 30 cents to 70 before the reports. There are strong opportunities for them in the coming year with potential deals with drugmakers and distributors.
PresidentRobert McWhirter
Owned
Unlock Rating
$0.670

Stock price when the opinion was issued

biotechnology
BUY

Sernova Biotherapeutics Inc (SVA-T)

Jun 30, 2020
They make a tiny device that you implant into your chest to create insulin. The medical benefits are high and could have additional applications. Tests are exploring how the device can deliver other drugs into the body, and early results are promising. He sees a lot of upside.
PresidentRobert McWhirter
Owned
Unlock Rating
$0.280

Stock price when the opinion was issued

biotechnology
BUY

Sernova Biotherapeutics Inc (SVA-T)

Nov 25, 2019
The company is researching insulin therapy delivery technology. They are moving into human trials. It has potential to go beyond insulin delivery systems to other drugs as well.
PresidentRobert McWhirter
Owned
Unlock Rating
$0.190

Stock price when the opinion was issued

biotechnology
BUY

Sernova Biotherapeutics Inc (SVA-T)

Oct 21, 2019
He participated in a recent financing. They have a piece that is inserted under the skin and then inject it with insulin. There are plans to use this for other needs as well.
PresidentRobert McWhirter
Owned
Unlock Rating
N/A

Stock price when the opinion was issued

biotechnology
BUY

Sernova Biotherapeutics Inc (SVA-T)

Sep 30, 2019
They have an interesting implantable device that functions as an artificial pancreas. This replaces injecting insulin into diabetics. They are moving towards testing on people. It is quite positive.
PresidentRobert McWhirter
Owned
Unlock Rating
$0.260

Stock price when the opinion was issued

biotechnology
Showing 1 to 8 of 8 entries
  • «
  • ‹
  • 1
  • ›
  • »

Sernova Biotherapeutics Inc (SVA-T) Rating

Ranking : 1 out of 5

Star iconStar empty iconStar empty iconStar empty iconStar empty icon

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Sernova Biotherapeutics Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Sernova Biotherapeutics Inc (SVA-T) Frequently Asked Questions

What is Sernova Biotherapeutics Inc stock symbol?

Sernova Biotherapeutics Inc is a OTC stock, trading under the symbol SVA-T on the (). It is usually referred to as or SVA-T

Is Sernova Biotherapeutics Inc a buy or a sell?

In the last year, there was no coverage of Sernova Biotherapeutics Inc published on Stockchase.

Is Sernova Biotherapeutics Inc a good investment or a top pick?

Sernova Biotherapeutics Inc was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Sernova Biotherapeutics Inc .

Why is Sernova Biotherapeutics Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Sernova Biotherapeutics Inc worth watching?

0 stock analysts on Stockchase covered Sernova Biotherapeutics Inc In the last year. It is a trending stock that is worth watching.

What is Sernova Biotherapeutics Inc stock price?

On , Sernova Biotherapeutics Inc (SVA-T) stock closed at a price of $.

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

ARTG-X -0.11$34.92
CNQ-T -1.91$43.97
FRU-T -0.38$13.56
RCH-T 1.22$35.5
CHE.UN… -0.05$13.38

Today's Top Picks

IAK-N -1.631$131.8292
AQN-T -0.03$8.11
AMGN-Q -5.3$290.13
META-Q -28.21$705.3
EXPE-Q -6.48$210.33

Popular Articles

Latest Sell Signals

EMCC-N 0$24.1748
AVGO-Q -20.39$324.63
AYA-T -0.33$15.67
EFR-T 0.8$28.37
MFC-T -0.37$44.41

Most Recent Experts

Hap (Robert) Sneddon FCSI

Hap (Robert) Sneddon FCSI

Castlemoore Inc.

Stockchase Insights

Stockchase Insights

5i Research

Stan Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

The Weekly Buzzing Stocks by Billy Kawasaki

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Kim Bolton

Kim Bolton

Black Swan Dexteritas

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: hello@stockchase.com.

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© Stockchase Inc. by Wealthica